Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent ... PR Newswire (press release) ABBOTT PARK, Ill., April 9, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME™ Everolimus Eluting Coronary Stent System ... Healthcare Sector Review: Regulating Heart Devices, Abbott Approved in Japan |
